In line with this, clinicopathological data indicated that hypermethylation of the -132 site may be an effective indicator for histological grade and estrogen receptor status in BRCA1-mutated breast cancer tissues (Table 1). The gene discussed is BRCA1; the disease is breast carcinoma.